Acadian Asset Management’s AYTU BioPharma AYTU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22K | Sell |
10,237
-4,385
| -30% | -$9.42K | ﹤0.01% | 1576 |
|
|
2025
Q1 | $17K | Hold |
14,622
| – | – | ﹤0.01% | 1538 |
|
|
2024
Q4 | $24K | Hold |
14,622
| – | – | ﹤0.01% | 1529 |
|
|
2024
Q3 | $34K | Hold |
14,622
| – | – | ﹤0.01% | 1900 |
|
|
2024
Q2 | $41K | Hold |
14,622
| – | – | ﹤0.01% | 1622 |
|
|
2024
Q1 | $44K | Hold |
14,622
| – | – | ﹤0.01% | 1396 |
|
|
2023
Q4 | $41K | Sell |
14,622
-7,915
| -35% | -$22.2K | ﹤0.01% | 1480 |
|
|
2023
Q3 | $59K | Hold |
22,537
| – | – | ﹤0.01% | 1405 |
|
|
2023
Q2 | $35K | Hold |
22,537
| – | – | ﹤0.01% | 1569 |
|
|
2023
Q1 | $50K | Buy |
22,537
+2,640
| +13% | +$5.86K | ﹤0.01% | 1514 |
|
|
2022
Q4 | $75K | Buy |
+19,897
| New | +$75K | ﹤0.01% | 1492 |
|
|
2019
Q4 | – | Sell |
-243
| Closed | -$58K | – | 1881 |
|
|
2019
Q3 | $58K | Buy |
+243
| New | +$58K | ﹤0.01% | 1583 |
|
|
2019
Q2 | – | Sell |
-216
| Closed | -$72K | – | 1792 |
|
|
2019
Q1 | $72K | Buy |
216
+143
| +196% | +$47.7K | ﹤0.01% | 1599 |
|
|
2018
Q4 | $11K | Hold |
73
| – | – | ﹤0.01% | 1601 |
|
|
2018
Q3 | $40K | Buy |
73
+27
| +59% | +$14.8K | ﹤0.01% | 1412 |
|
|
2018
Q2 | $48K | Buy |
46
+43
| +1,433% | +$44.9K | ﹤0.01% | 1394 |
|
|
2018
Q1 | $7K | Buy |
+3
| New | +$7K | ﹤0.01% | 1577 |
|